poisar

Stocks · News reference

8-K/A filing — DNA X, Inc. (SONM)

SEC EDGARSEC EDGAR

Filed: 2026-07-09 AccNo: 0001493152-26-032680 Size: 229 KB Item 3.02: Unregistered Sales of Equity Securities Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaBenzinga Newsdesk

    DNA X Q2 EPS $(0.91) Up From $(14.15) YoY

    DNA X (NASDAQ:SONM) reported quarterly losses of $(0.91) per share. This is a 93.57 percent increase over losses of $(14.15) per share from the same period last year.